See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Betaferon, Betaseron
What is Interferon beta-1b SubQ Injection? Interferon beta-1b is a drug in the interferon family used to treat multiple sclerosis. It is administered by sub-cutaneous injection and has been shown to slow the advance of the affliction as well as reduce the frequency of attacks.
See more information, including instructions, precautions, side effects, and interactions.
557 patients in the community are taking or have taken Interferon beta-1b SubQ Injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 457 | 82% |
| Other | 17 | 3% |
| Don't know | 6 | 1% |
| Fatigue | 6 | 1% |
| General health | 6 | 1% |
| Stiffness/spasticity | 4 | <1% |
| Difficulty walking | 3 | <1% |
| disease-related symptoms | 2 | <1% |
| Sexual dysfunction | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Bladder problems | 1 | <1% |
| Brain fog | 1 | <1% |
| Pain | 1 | <1% |
| Cognition | 1 | <1% |
| Vision | 1 | <1% |
| Headaches/ Migraines | 1 | <1% |
Based on the patients currently taking Interferon beta-1b SubQ Injection.
Top 10 (Show all)
All (Show Top 10)
| 0 mcg Daily | 0 mg Daily | 0 mg Weekly | 0 mcg | 0 mg | 0 | 0.03 mg As needed | 0.25 mg As needed | 0.275 mg As needed | 0.3 mg As needed | 0.44 mcg As needed | 1 mcg As needed | 1 mg As needed | 15 mg As needed | 20 mg As needed | 0.125 mg Weekly | 0.3 mg Every Other Week | 0.25 mg Weekly | 0.04 mg Daily | 0.3 mg Weekly | 0.075 mg Daily | 0.15 mg | 0.25 mg Daily | 0.25 mcg | 0.25 mg | 0.9 mg Weekly | 1 mg Weekly | 4.5 mg Monthly | 0.3 mg As needed | 0.3 mg Daily | 0.3 mcg | 0.3 mg | 1.05 mg Weekly | 0.44 mg | 0.25 mg Daily | 0.5 mg | 0.5 | 0.3 mg As needed | 0.3 mcg Daily | 0.3 mg Daily | 0.3 mg One time | 0.75 mcg | 0.75 mg | 3 mcg Weekly | 3 mg Weekly | 0.5 mg Daily | 1 mg Daily | 1 other Daily | 1 g | 1 mcg | 1 mg | 1 | 4 mg Weekly | 1.3 mg | 0.75 other Daily | 1.5 mg | 0.9 mg Weekly | 1 mg Daily | 2 mg | 3 mg | 15 mg Weekly | 2.5 mcg Daily | 3 mg Daily | 20 mg | 21 mcg | 25 mg | 30 mg | 44 mcg | 40 mcg | 44 mcg | 44 mg | 300 mg Weekly | 100 mcg | 100 mg | 200 mcg | 200 mg | 200 | 250 mcg | 250 mg | 300 mg | 250 mcg Daily | 8000000 intl units Daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
9
|
1
|
11
|
4
|
48
|
26
|
1
|
1
|
1
|
8
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
5
|
1
|
2
|
1
|
1
|
11
|
5
|
2
|
2
|
1
|
15
|
2
|
49
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
74
|
1
|
1
|
4
|
1
|
3
|
1
|
1
|
1
|
1
|
2
|
24
|
3
|
1
|
1
|
1
|
2
|
1
|
8
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Interferon beta-1b SubQ Injection or how long patients were taking Interferon beta-1b SubQ Injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 63 | 38% | |
| Did not seem to work | 57 | 35% | |
| Doctor's advice | 55 | 33% | |
| Other | 36 | 22% | |
| Personal research | 4 | 2% | |
| Not indicated | 4 | 2% | |
| Course of treatment ended | 3 | 2% | |
| Expense | 2 | 1% |
Results from 48 patient evaluations. See the overall results and all individual evaluations.
| Major | 15% | 6 |
|---|---|---|
| Moderate | 15% | 6 |
| Slight | 20% | 8 |
| None | 15% | 6 |
| Can't tell | 37% | 15 |
Slow my MS progress
| Severe | 15% | 7 |
|---|---|---|
| Moderate | 25% | 12 |
| Mild | 48% | 23 |
| None | 13% | 6 |
Top reported side-effects include: flu like symtoms, soreness at injection site, Bruising
Summary results are based on 48 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Interferon beta-1b SubQ Injection